Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease
argenx SE American Depositary Shares · Now $836.09
-1.1% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
+1.1%
7d
-1.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS